The most prescribed drugs in the United States

0


[ad_1]

Who are the biggest pharmaceutical companies in the world?

Some of the world’s largest pharmaceutical companies have played a central role in the COVID-19 pandemic.

However, it is probably not surprising that the pandemic has also been formidable for many healthcare companies. In fact, in 2020 alone, the world’s 50 largest pharmaceutical companies have yet combined for a huge $ 851 billion in income.

In this graph, using data from Market capitalization of companies, we list the world’s largest pharmaceutical companies by market capitalization. It should be noted that this list also includes healthcare companies that work closely with pharmaceuticals including biotechnology, pharmaceutical retailers, clinical labs, etc.

Editor’s note: Some key companies like GSK and AbbVie were missing in a previous version of this chart. They were unfortunately not included in the original source and we are now working to ensure that there are no other smaller omissions. Thanks to everyone who sent in corrections.

Pharmaceutical leaders

For starters, here are the top five pharmaceutical companies in the world right now by market cap:

1. Johnson & Johnson

The pharmaceutical and consumer goods giant is worth $ 428.7 billion in market capitalization. They developed the third vaccine authorized in the United States and were named among the TIME100 List of the most influential companies in 2021.

2. Rock

The Swiss pharmaceutical giant is at the forefront of oncology, immunology, infectious diseases, ophthalmology and neuroscience. In 2019, the pharmaceutical segment of Roche sales increased from 16% in good health to $ 53 billion.

3. Pfizer

Despite being the leading manufacturer of COVID-19 vaccines in North America, Pfizer has slipped in the rankings to third place. The company recently gained momentum, in particular during the last quarter, with a turnover in Q2’2021 of $ 19.0 billion, reflecting operational growth of 86% compared to 2020.

4. Eli Lilly

Eli Lilly has taken an important step towards establishing itself as a leader in the pharmaceutical industry. Have a market capitalization value of $ 125 billion in 2019, Eli Lilly jumped to a present value of $ 214.9 billion, a significant growth of 72%.

5. Novartis

The second largest pharmaceutical company in Switzerland, Novartis has been the face of the pharmaceutical industry for around 25 years. The leading manufacturer of the most recognizable drugs on the market achieved sales of over 48 billion dollars in 2020, an increase of 3% compared to 2019.

Here’s how all of the world’s biggest pharmaceutical companies stack up:

Company rank Company Name Market cap value Country
1 Johnson & johnson
JNJ
$ 428.66 billion United States
2 rock
RHHBY
$ 320.41 billion Swiss
3 Pfizer
PFE
$ 219.39 billion United States
4 Eli lilly
THERE IS
G $ 208.99 United States
5 Novartis
NVS
$ 207.70 billion Swiss
6 AbbVie
ABBV
$ 202.60 billion United States
7 Merck
MRK
$ 191.67 billion United States
8 Novo Nordisk
NVO
$ 187.83 billion 🇩🇰 Denmark
9 Astrazeneca
AZN
$ 152.28 billion UK
ten Bristol Myers Squibb
BMY
$ 145.80 billion United States
11 Amgen
AMGN
$ 136.50 billion United States
12 Sanofi
SNY
$ 130.37 billion France
13 CVS Health
CVS
$ 110.49 billion United States
14 GlaxoSmithKline
GSK
$ 104.30 billion UK
15 CSL
CSL.AX
$ 103.10 billion Australia
16 Gilead Sciences
BROWN
$ 83.62 billion United States
17 Modern
MRNA
$ 83.25 billion United States
18 Merck KGaA
MRK.DE
$ 80.61 billion Germany
19 Bayer
BAYZF
$ 59.43 billion Germany
20 Jiangsu Hengrui Medicine
600276.SS
$ 58.51 billion China
21 Regeneron Pharmaceuticals
REGN
$ 55.83 billion United States
22 Biogenic
BIIB
G $ 55.00 United States
23 BioNTech
BNTX
$ 54.23 billion Germany
24 Pharmaceutical Takeda
TAK
$ 52.67 billion Japan
25 Lonza
LONN.SW
$ 52.16 billion Swiss
26 Alliance of Walgreens boots
WBA
$ 45.05 billion United States
27 Celltrion
068270.KS
$ 33.80 billion South Korea
28 Astellas Pharma
ALPMF
$ 33.42 billion Japan
29 BeiGene
BGNE
$ 31.65 billion China
30 Eisai
4523.T
$ 31.20 billion Japan
31 West Pharmacy
WST
$ 26.59 billion United States
32 Hansoh Pharma
3692.HK
$ 26.00 billion China
33 LabCorp
LH
$ 25.97 billion United States
34 Otsuka Holdings
4578.T
$ 23.15 billion Japan
35 Therapeutic horizon
HZNP
$ 21.13 billion Ireland
36 Alnylam Pharmaceuticals
ALNY
$ 20.42 billion United States
37 Kyowa Kirin
4151.T
$ 18.85 billion Japan
38 Catalent
CTLT
$ 18.74 billion United States
39 Sino Biopharmaceutical
1177.HK
$ 18.48 billion Hong Kong
40 Bio-Techné
TECHNOLOGY
$ 17.25 billion United States
41 PPD
PPD
$ 16.26 billion United States
42 Argenx
ARGX
$ 16.03 billion Netherlands
43 Shionogi
4507.T
$ 15.29 billion Japan
44 Dr. Reddy’s
RDY
$ 11.88 billion India
45 Teva Pharmaceutical Industries
SUITS YOU
$ 11.21 billion Israel
46 Ono Pharmaceutical
4528.T
$ 11.12 billion Japan
47 ICNE plc
ICLR
$ 11.09 billion Ireland
48 Health Bausch
BHC
$ 10.47 billion Canada
49 CRISPR Therapeutics
CRSP
$ 10.42 billion Swiss
50 Curévac
HVAC
$ 10.33 billion Germany
51 Hualan Biological Engineering
002007.SZ
$ 10.31 billion China
52 Vifor Pharma
VIFN.SW
$ 9.49 billion Swiss
53 Neurocrine biosciences
NBIX
$ 9.45 billion United States
54 Sinopharm
1099.HK
$ 9.42 billion China
55 BridgeBio Pharma
BBIO
$ 8.89 billion United States
56 Cadila Health
CADILAHC.NS
$ 8.59 billion India
57 Sumitomo Dainippon Pharma
4506.T
$ 8.16 billion Japan
58 Tilray
TLRY
$ 7.89 billion Canada
59 Ascendis Pharma
ASND
$ 7.51 billion 🇩🇰 Denmark
60 Evotec
EVT.F
$ 7.19 billion Germany
61 Lupine Limited
LUPINE.NS
$ 7.04 billion India
62 Gland Pharma
GLAND.NS
$ 7.01 billion India
63 Exelixis
EXEL
$ 6.95 billion United States
64 GW Pharmaceuticals
GWPH
$ 6.81 billion UK
65 KOBAYASHI Pharmaceutical
4967.T
$ 6.78 billion Japan
66 Torrent Pharmaceutical
TORNTPHARM.NS
$ 6.61 billion India
67 Biocon
BIOCON.NS
$ 6.43 billion India
68 PeptiDream
4587.T
$ 6.32 billion Japan
69 Therapeutic Zarephath
SRPT
$ 6.25 billion United States
70 Perrigo
PRGO
$ 6.21 billion Ireland
71 Orion Company
ORNAV.HE
$ 6.11 billion Finland
72 Lundbeck
LDB.F
$ 6.04 billion 🇩🇰 Denmark
73 AbCellera
ABCL
$ 5.87 billion Canada
74 Adaptive biotechnologies
ADPT
$ 5.69 billion United States
75 Intellia Therapeutics
NTLA
$ 5.62 billion United States
76 Santen Pharmaceutical
4536.T
$ 5.49 billion Japan
77 Japanese shinyaku
4516.T
$ 5.46 billion Japan
78 Therapeutic bundle
SHINE
$ 5.43 billion United States
79 Reata Pharmaceuticals
RETA
$ 5.15 billion United States
80 Biovitrum Orphan Swedish
SOBI.ST
$ 5.13 billion Sweden
81 BB Biotech
BION.SW
$ 5.08 billion Swiss
82 Alkem Laboratories
ALKEM.NS
$ 5.00 billion India
83 Abbott India
ABBOTINDIA.NS
$ 4.69 billion India
84 Laurus Laboratories
LAURUSLABS.NS
$ 4.44 billion India
85 Pharmaceutical Taisho
4581.T
$ 4.39 billion Japan
86 Hanmi Pharmaceuticals
008930.KS
$ 4.22 billion South Korea
87 Alkermes
ALKS
$ 3.87 billion Ireland
88 Therapeutic Karuna
KRTX
$ 3.71 billion United States
89 Shinpoong Pharmacy
019170.KS
$ 3.65 billion South Korea
90 NantKwest
NK
$ 3.55 billion United States
91 Ipca Laboratories
IPCALAB.NS
$ 3.41 billion India
92 Nektar Therapeutics
NKTR
$ 3.02 billion United States
93 BioCryst Pharmaceuticals
BCRX
$ 3.01 billion United States
94 Vericel
VCEL
$ 2.96 billion United States
95 Dicerna pharmacy
CDNA
$ 2.84 billion United States
96 Rocket Pharmaceuticals
RCKT
$ 2.74 billion United States
97 Axsome Therapeutics
AXSM
$ 2.65 billion United States
98 Natco Pharma
NATCOPHARM.NS
$ 2.63 billion India
99 Pharmaceutical still
APLLTD.NS
$ 2.59 billion India
100 Editas Medicine
EDIT
$ 2.54 billion United States

The world’s largest exporters and importers of pharmaceuticals

According to the World Trade Organization (WTO), these countries exported the highest number of pharmaceutical products in 2019:

Rank Country Export value (US $ billion)
1 Germany $ 91.4
2 Swiss $ 84.8
3 WE $ 55.7
4 Belgium $ 55.7
5 Ireland $ 55.4

On the other hand, here are the biggest importers over the same period.

Rank Country Import value (US $ billion)
1 WE $ 132.4
2 Germany $ 59.4
3 Belgium $ 47.3
4 China $ 35.7
5 Netherlands $ 33.5

This position is hardly surprising for the United States, where six of the world’s 10 largest pharmaceutical companies are located. The country also captures 45% of the world market.

The future of pharmaceutical companies

If the response to the COVID-19 pandemic has taught us anything, it’s that in building a patient-centered future, the pharmaceutical industry plays a key role. He must constantly find new ways to personalize drugs while researching and developing new tools and drugs.

Kissing disruptive technologies like 3D printed drugs, artificial intelligence guided therapies and preventative medicine while working with regulatory agencies, pharmaceutical companies will benefit from a digital revolution.

In addition, emerging markets will have a greater influence on the global pharmaceutical market in the years to come. Even though the “big pharmaceutical companies” will continue to rake in the huge profits they make each year, their dependence on countries like Brazil and India for drug research and production will have a significant impact on people. years to come.

[ad_2]

Share.

Leave A Reply